Skip to content

Predictive value of preoperative inflammation-related factors for postoperative analgesic consumption in patients with inflammatory bowel disease: a retrospective observational study.

Predictive value of preoperative inflammation-related factors for postoperative analgesic consumption in patients with inflammatory bowel disease: a retrospective observational study. - Predictive value of preoperative inflammation for postoperative analgesic consumption in IBD patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031198
Enrollment
200
Registered
2018-02-28
Start date
2017-09-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

None listed

Sponsors

Department of Anesthesia, Yokohama Municipal Citizens' Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Underwent laparotomy for inflammatory bowel syndrome. Used intravenous fentanyl for patient-controlled postoperative analgesia. Have temporal recording of postoperative analgesic consumption. Have electronic perioperative medical records.

Exclusion criteria

Exclusion criteria: Hepatic failure Renal failure Hematological disease Unable to use patient-controlled analgesia Under preoperative influence of narcotics Unwilling to participate Defect in medical records

Design outcomes

Primary

MeasureTime frame
Postoperative consumption of fentanyl given by intravenous patient-controlled analgesia (24, 48, and 72 hours after surgery).

Secondary

MeasureTime frame
Postoperative outcomes (complications, recovery, length of stay)

Countries

Japan

Contacts

Public ContactGaku Inagawa

Yokohama Municipal Citizens' Hospital Department of Anesthesia

yokohama.city.anesth@gmail.com045-316-4580

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026